Abciximab, a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro,...
9 KB (671 words) - 19:42, 20 December 2023
fibrinogen. The gpIIb/IIIa receptor is a target of several drugs including abciximab, eptifibatide, and tirofiban. Once platelets are activated, granules secrete...
5 KB (500 words) - 06:24, 21 December 2023
a class of antiplatelet agents. Several GpIIb/IIIa inhibitors exist: abciximab (abcixifiban) (ReoPro) eptifibatide (Integrilin) tirofiban (Aggrastat)...
2 KB (175 words) - 18:45, 17 January 2024
(Persantine) Glycoprotein IIB/IIIA inhibitors (intravenous use only) Abciximab (ReoPro) Eptifibatide (Integrilin) Tirofiban (Aggrastat) Irreversible...
18 KB (1,752 words) - 10:58, 11 August 2024
GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market. Eptifibatide...
11 KB (947 words) - 16:29, 11 May 2024
Churchill Livingstone. pp. 241, for the examples infliximab, basiliximab, abciximab, daclizumab, palivusamab, gemtuzumab, alemtuzumab and rituximab, and mechanism...
48 KB (4,964 words) - 04:26, 20 October 2024
(INN) abanoquil (INN) abarelix (INN) abatacept (USAN) Abasol Abbokinase abciximab (INN) abecarnil (INN) Abecma abediterol (INN) Abegrin Abelcet Abenol abexinostat...
2 KB (188 words) - 05:47, 19 October 2024
Developed the drug that is recommended for all cardiac angioplasties (abciximab) 1974 Created the first MRI image of a living organism Discovered the...
153 KB (13,914 words) - 19:41, 18 October 2024
Sakmar was acting-president from 2002.) Barry Coller, who invented the Abciximab, currently serves as the Vice President for Medical Affairs. In all, as...
37 KB (3,197 words) - 14:01, 13 October 2024
LifeScan Ortho Clinical Diagnostics Tasmanian Alkaloids Legacy brands Abciximab Actifed Axert Bactidol Bapineuzumab Benecol (US license) Benylin Caladryl...
7 KB (764 words) - 16:32, 18 September 2024
form-factor for monoclonal antibodies designated for therapeutic use. The Fab abciximab, which inhibits blood clotting, works by disabling glycoprotein IIb/IIIa...
6 KB (688 words) - 10:22, 9 September 2024
points to the widely accepted pronunciation of any given INN. For example, abciximab is predictably /æbˈsɪksɪmæb/, because for INNs ending in -ciximab, the...
26 KB (2,150 words) - 12:06, 11 September 2024
physician known for his research in platelet physiology and for inventing the Abciximab. He is the David Rockefeller Professor, Physician-In-Chief, and Vice President...
9 KB (749 words) - 18:17, 24 September 2023
for plaque psoriasis in September 2006. Centocor also markets ReoPro (abciximab), a biologic agent indicated as an adjunct to coronary angioplasty (PTCA)...
33 KB (3,169 words) - 05:41, 1 October 2024
1. ABACAVIR 2. ABCIXIMAB 3. ACAMPROSATE CALCIUM 4. ACEBUTOL HYDROCHLORIDE 5. ACLARUBICIN 6. ALBENDAZOLE 7. ALCLOMETASONE DIPROPIONATE 8. ACTILYSE 9. ACYCLOVIR...
16 KB (253 words) - 16:47, 23 February 2023
calcium B01AC09 Epoprostenol B01AC10 Indobufen B01AC11 Iloprost B01AC13 Abciximab B01AC15 Aloxiprin B01AC16 Eptifibatide B01AC17 Tirofiban B01AC18 Triflusal...
3 KB (346 words) - 19:19, 12 March 2024
from the original on 15 July 2020. Retrieved 23 January 2020. "ReoPro Abciximab". DailyMed. 4 May 2020. Archived from the original on 6 September 2022...
137 KB (4,083 words) - 21:25, 19 October 2024
stem. Examples of chimeric antibodies approved for human therapy include abciximab (ReoPro), basiliximab (Simulect), cetuximab (Erbitux), infliximab (Remicade)...
14 KB (1,787 words) - 23:05, 9 January 2024
g. insulin and human growth hormone), antibodies (e.g. infliximab and abciximab) and vaccines; antibodies and enzymes used in diagnostics; industrial...
5 KB (657 words) - 03:49, 15 May 2024
adalumab (ada-li-u-mab). After 2017, it would be adalimab (ada-li-mab). Abciximab is a commonly used medication to prevent platelets from clumping together...
38 KB (3,088 words) - 05:02, 8 August 2024
Ticagrelor Ticlopidine Desmopressin Factor VIIa Thrombopoietin mimetics Abciximab Eptifibatide Tirofiban Others: oprelvekin, romiplostim, eltrombopag, argatroban...
71 KB (8,533 words) - 15:40, 8 October 2024
Drug Mechanism of action Indications Toxicity Abciximab A monoclonal antibody that binds to the glycoprotein receptor IIb/IIIa on activated platelets...
20 KB (1,640 words) - 02:38, 30 March 2024
(INN) renytoline (INN) renzapride (INN) ReoPro (Eli Lilly). Redirects to abciximab. repagermanium (INN) repaglinide (INN) Repan reparixin (USAN) Repatha...
6 KB (335 words) - 02:51, 12 October 2024
the efficacy of several angioplasty approaches, including tirofiban and abciximab infusion, as well as the implantation of both Sirolimus-Eluting and uncoated...
27 KB (2,986 words) - 21:09, 28 February 2024
(2003). "Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to...
30 KB (3,470 words) - 03:58, 25 December 2023
date Route Type Target Indication (Targeted disease) BLA STN Drug Label abciximab ReoPro Centocor 12/22/1994 intravenous chimeric Fab GPIIb/IIIa Percutaneous...
59 KB (4,170 words) - 07:03, 20 October 2024
non-dihydropyridines diltiazem verapamil Eplerenone Finerenone Spironolactone Abciximab Aspirin Cangrelor Clopidogrel Eptifibatide Prasugrel Ticagrelor Tirofiban...
5 KB (345 words) - 07:24, 2 July 2024
Metzler H, Rehak P, März W, Halwachs-Baumann G. Different effects of abciximab and cytochalasin D on clot strength in thrombelastography. J Thromb Haemost...
19 KB (2,428 words) - 07:42, 19 May 2024
by Jorge Benach Drugs that were developed by faculty of RSOM include: Abciximab (for cardiac angioplasty) by Barry S. Coller Doxycycline (for periodontal...
19 KB (1,974 words) - 18:00, 11 May 2024
patients undergoing percutaneous coronary intervention, consisting of abciximab, eptifibatide and tirofiban. Patients presenting with ST elevation that...
54 KB (5,225 words) - 10:48, 21 July 2024